Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status?
Drummond
M
M
D001315:Australia; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004341:Drug Evaluation / Q000379:methods*; D017408:Guidelines as Topic; D007356:Insurance, Pharmaceutical Services / Q000592:standards*; D009864:Ontario; D012051:Reimbursement Mechanisms